Chairman of the Board and Primary Insider, Frode Marc Bohan, has on 31st
December 2018 through his company, Bohan & Co AS, purchased 200 000 shares in
NattoPharma ASA at a price of NOK 8.00 per share. The shares were acquired from
NxT Capital Ltd., a company owned by Frode Marc Bohan.
At the same time, Bohan & Co AS has bought 75 000 shares at a price per share of
NOK 8.00 from Katarzyna Maresz. Katarzyna Maresz is a primary insider and a
member of the Board of Directors in NattoPharma ASA. After this transaction
Katarzyna Maresz control 25 000 shares and 100 000 options in NattoPharma ASA.
Further to this, Bohan & Co AS has agreed to transfer as a gift 10 000 shares to
Stella Bohan and 10 000 shares to Alexander Rye Bohan-Ellingsen, both being
related parties to Frode Marc Bohan. Stella Bohan and Alexander Rye
Bohan-Ellingsen will both hold 10 000 shares each in NattoPharma ASA after this
Frode Bohan, chairman of the Board of Directors and primary insider in
NattoPharma ASA, will directly and indirectly through Bohan & Co AS (1,288,455
shares), TG Montgomery AS (1,735,122 shares), NxT Capital Ltd (252 852 shares)
and the related parties Patrycja Ratusinska (350,000 shares), Stella Bohan
(10,000 shares) and Alexander Rye Bohan-Ellingensen (10,000 shares) control 3
646 429 shares in NattoPharma ASA, representing 20,1% of the outstanding shares.
Mr. Bohan also hold 200 000 options in the company.